Endocrine, Genetic and Metabolic Diseases

Phenotype and genetic characteristics of diabetes mellitus in children

  • Kaichuang ZHANG ,
  • Lili LIANG ,
  • Huiwen ZHANG ,
  • Ruifang WANG ,
  • Yi YANG ,
  • Yuning SUN ,
  • Lianshu HAN ,
  • Yongguo YU ,
  • Wenjuan QIU
Expand
  • Department of Pediatric Endocrinology and Genetic Metabolism, Shanghai Institute for Pediatric Research, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China

Received date: 2022-02-28

  Online published: 2022-05-13

Abstract

Objective Objective To determine phenotype and genetic characteristics of monogenic diabetes in children. Methods Clinical manifestations and laboratory data at initial diagnosis of 76 children with diabetes admitted to our department from August 2020 to December 2021 were retrospectively analyzed. Whole exome sequencing was performed in 21 patients with suspected monogenic diabetes. Results A total of seven cases of monogenic diabetes were identified by whole exome sequencing (WES), all of which were maturity-onset diabetes of the young (MODY). Three cases of MODY2 were caused by GCK variants, and three cases of MODY3 were caused by HNF1A variants and one case of MODY10 caused by INS variant. Two novel variants were identified, including c.1124T>G (p.V375G) in GCK and c.110A>T (p.E37V) in INS. Five of the 7 patients (5/7) with MODY had no typical symptoms of diabetes and were admitted to the hospital due to incidentally elevated glucose level. The level of blood glucose and glycosylated hemoglobin in the MODY group (n=7) were lower than those in the T1DM group (n=62) (P<0.05), and showed no significant difference compared with those of T2DM group (n=7). The levels of insulin and C-peptide in the MODY group were higher than those in the T1DM group (P<0.05), and were significantly lower than those in the T2DM group (P<0.05). In addition, a T1DM child with retarded mental development received an additional diagnosis of 18p deletion syndrome by WES, and another T2DM child with sustained elevated liver aminotransferase received an additional diagnosis of Wilson Disease by WES. Conclusions MODY is the common type of monogenic diabetes. This study expands the mutation spectrum of MODY. When diabetes patient present with extra-pancreatic manifestations, the combination of other genetic disorders should be considered.

Cite this article

Kaichuang ZHANG , Lili LIANG , Huiwen ZHANG , Ruifang WANG , Yi YANG , Yuning SUN , Lianshu HAN , Yongguo YU , Wenjuan QIU . Phenotype and genetic characteristics of diabetes mellitus in children[J]. Journal of Clinical Pediatrics, 2022 , 40(5) : 345 -348 . DOI: 10.12372/jcp.2022.22e0284

References

[1] Adler A, Bennett P, Colagiuri S, et al. Classification of diabetes mellitus[EB/OL]. (2019-04-21)[2020-02-06]. https://www.who.int/publications/i/item/classification-of-diabetes-mellitus.
[2] Hattersley AT, Saw G, Polak M, et al. ISPAD clinical practice consensus guidelines 2018: the diagnosis and management of monogenic diabetes in children and adolescents[J]. Pediatr Diabetes, 2018, 19(Suppl 27): 47-63.
[3] Glotov OS, Serebryakova EA, Turkunova ME, et al. Whole exome sequencing in Russian children with non type 1 diabetes mellitus reveals a wide spectrum of genetic variants in MODY related and unrelated genes[J]. Mol Med Rep, 2019, 20(6): 4905-4914.
[4] Ming-Qiang Z, Yang-Li D, Ke H, et al. Maturity onset diabetes of the young (MODY) in Chinese children: genes and clinical phenotypes[J]. J Pediatr Endocrinol Metab, 2019, 32(7): 759-765.
[5] Sun Y, Hu G, Luo J, et al. Mutations in methionyl-tRNA synthetase gene in a Chinese family with interstitial lung and liver disease, postnatal growth failure and anemia[J]. J Hum Genet, 2017, 62(6): 647-651.
[6] Bansal V, Gassenhuber J, Phillips T, et al. Spectrum of mutations in monogenic diabetes genes identified from high-throughput DNA sequencing of 6888 individuals[J]. BMC Med, 2017, 15(1): 213.
[7] Li M, Wang S, Xu K, et al. High prevalence of a monogenic cause in Han Chinese diagnosed with type 1 diabetes, partly driven by nonsyndromic recessive WFS1 mutations[J]. Diabetes, 2020, 69(1): 121-126.
[8] Pihoker C, Gilliam LK, Ellard S, et al. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth[J]. J Clin Endocrinol Metab, 2013, 98(10): 4055-4062.
[9] Li X, Ting TH, Sheng H, et al. Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY)[J]. BMC Pediatr, 2018, 18(1): 101.
[10] Liang H, Zhang Y, Li M, et al. Recognition of maturity-onset diabetes of the young in China[J]. J Diabetes Investig, 2021, 12(4): 501-509.
[11] Chakera AJ, Steele AM, Gloyn AL, et al. Recognition and management of individuals with hyperglycemia because of a heterozygous glucokinase mutation[J]. Diabetes Care, 2015, 38(7): 1383-1392.
[12] Stride A, Shields B, Gill-Carey O, et al. Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia[J]. Diabetologia, 2014, 57(1): 54-56.
[13] Awa WL, Thon A, Raile K, et al. Genetic and clinical characteristics of patients with HNF1A gene variations from the German-Austrian DPV database[J]. Eur J Endocrinol, 2011, 164(4): 513-520.
[14] Boesgaard TW, Pruhova S, Andersson EA, et al. Further evidence that mutations in INS can be a rare cause of Maturity-Onset Diabetes of the Young (MODY)[J]. BMC Med Genet, 2010, 11: 42.
[15] Dusatkova L, Dusatkova P, Vosahlo J, et al. Frameshift mutations in the insulin gene leading to prolonged molecule of insulin in two families with Maturity-Onset Diabetes of the Young[J]. Eur J Med Genet, 2015, 58(4): 230-234.
[16] Xiao X, Liu L, Xiao Y, et al. Novel frameshift mutation in the insulin (INS) gene in a family with maturity onset diabetes of the young (MODY)[J]. J Diabetes, 2019, 11(1): 83-86.
Outlines

/